Current methods of producing collagen fibers for tissue engineering struggle to replicate the complex biomechanical and biochemical properties of natural collagen, hindering the development of effective regenerative medicine solutions. Existing manufacturing processes often lack the scalability needed to meet the growing demand for reliable biomaterials in applications like 3D bioprinting and cell culturing.

3D BioFibR utilizes a patented dry-spinning technology to produce CollaFibR™, collagen fibers that closely mimic the structure and function of native collagen. Their automated manufacturing system enables the commercial-scale production of these fibers, addressing the limitations of traditional methods. CollaFibR™ serves as a versatile biomaterial for tissue engineering, enhancing the performance of 3D bioprinting additives, hydrogels, and cellular scaffolds used in both 2D and 3D cell and tissue cultures. The technology provides researchers and manufacturers with a consistent and scalable source of high-quality collagen fibers.

Patented dry-spinning technology for collagen fiber production

Automated manufacturing system enabling commercial-scale production

CollaFibR™ fibers that mimic the biomechanical and biochemical properties of natural collagen

Suitable for use as additives in 3D bioprinting

Compatible with hydrogels for improved tissue engineering applications

Effective as cellular scaffolds for 2D and 3D cell and tissue culture

The primary target audience includes researchers and manufacturers in the fields of tissue engineering, regenerative medicine, 3D bioprinting, and cell culture.